These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23350250)

  • 21. Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.
    Lemaitre M; Leruez-Ville M; De Lamballerie XN; Salez N; Garrone P; Fluckiger AC; Klatzmann D; Carrat F
    Clin Microbiol Infect; 2011 May; 17(5):732-7. PubMed ID: 20731679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A lower than expected adult Victorian community attack rate for pandemic (H1N1) 2009.
    Grills N; Piers LS; Barr I; Vaughan LM; Lester R; Magliano DJ; Shaw JE; Carnie JA
    Aust N Z J Public Health; 2010 Jun; 34(3):228-31. PubMed ID: 20618261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overview of the winter wave of 2009 pandemic influenza A(H1N1)v in Vojvodina, Serbia.
    Petrović V; Seguljev Z; Cosić G; Ristić M; Nedeljković J; Dragnić N; Ukropina S
    Croat Med J; 2011 Apr; 52(2):141-50. PubMed ID: 21495196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological and serological surveillance of human pandemic influenza A virus infections during 2009-2010 in Thailand.
    Prachayangprecha S; Makkoch J; Vuthitanachot C; Vuthitanachot V; Payungporn S; Chieochansin T; Theamboonlers A; Poovorawan Y
    Jpn J Infect Dis; 2011; 64(5):377-81. PubMed ID: 21937818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Herd immunity against new influenza A (H1N1) in pre-vaccinated residents aged over 5 years in Beijing].
    Lu L; Liu DL; Zhang TG; Chen M; Zhang ZJ; Wang XL; Yang Z; Pang XH; Deng Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jun; 33(6):403-5. PubMed ID: 20979808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with infection by 2009 pandemic H1N1 influenza virus during different phases of the epidemic.
    Chao DY; Cheng KF; Li TC; Wu TN; Chen CY; Tsai CA; Chen JH; Chiu HT; Lu JJ; Su MC; Liao YH; Chan WC; Hsieh YH;
    Int J Infect Dis; 2011 Oct; 15(10):e695-701. PubMed ID: 21767970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sero-epidemiological survey on general community population to understand the infection status after the first wave of pandemic 2009 H1N1 influenza in Guangdong province].
    Li LH; Zhang X; Zhong HJ; Lin WQ; Zhang ZM; Li H; He JF; Lin JY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1329-31. PubMed ID: 21223657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents.
    Lu CY; Shao PL; Chang LY; Huang YC; Chiu CH; Hsieh YC; Lin TY; Huang LM
    Vaccine; 2010 Aug; 28(36):5864-70. PubMed ID: 20600484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Seroprevalence of pandemic influenza A (H1N1)pdm09 in two regions in Morocco following the 2010-2011 influenza season].
    El Rhaffouli H; El Boukhrissi F; Bajjou T; Laraqui A; Hilali F; Bahji M; El Harrak M; Lahlou Amine I
    Pathol Biol (Paris); 2013 Apr; 61(2):83-6. PubMed ID: 22728009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A seroepidemiological study of pandemic A/H1N1(2009) influenza in a rural population of Mali.
    Koita OA; Sangare L; Poudiougou B; Aboubacar B; Samake Y; Coulibaly T; Pronyk P; Salez N; Kieffer A; Ninove L; Flahault A; de Lamballerie X
    Clin Microbiol Infect; 2012 Oct; 18(10):976-81. PubMed ID: 22221838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among health care workers in two general hospitals after first outbreak in Kobe, Japan.
    Toyokawa T; Sunagawa T; Yahata Y; Ohyama T; Kodama T; Satoh H; Ueno-Yamamoto K; Arai S; Araki K; Odaira F; Tsuchihashi Y; Takahashi H; Tanaka-Taya K; Okabe N
    J Infect; 2011 Oct; 63(4):281-7. PubMed ID: 21723615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v).
    Skowronski DM; Janjua NZ; De Serres G; Purych D; Gilca V; Scheifele DW; Dionne M; Sabaiduc S; Gardy JL; Li G; Bastien N; Petric M; Boivin G; Li Y
    J Infect Dis; 2012 Dec; 206(12):1852-61. PubMed ID: 22872731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.
    Hancock K; Veguilla V; Lu X; Zhong W; Butler EN; Sun H; Liu F; Dong L; DeVos JR; Gargiullo PM; Brammer TL; Cox NJ; Tumpey TM; Katz JM
    N Engl J Med; 2009 Nov; 361(20):1945-52. PubMed ID: 19745214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of efficacy and safety of pandemic A/H1N1/2009 influenza vaccine in a group of health care workers.
    Mascagni P; Vicenzi E; Kajaste-Rudnitski A; Pellicciotta G; Monti A; Cervi C; Vitalucci R; Toffoletto F
    Med Lav; 2012; 103(3):220-9. PubMed ID: 22838300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.
    Gilca V; De Serres G; Hamelin ME; Boivin G; Ouakki M; Boulianne N; Sauvageau C; Dionne M; Gilca R; Skowronski D
    Vaccine; 2011 Dec; 30(1):35-41. PubMed ID: 22063386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
    Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
    Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.
    Nasreen S; Rahman M; Hancock K; Katz JM; Goswami D; Sturm-Ramirez K; Holiday C; Jefferson S; Branch A; Wang D; Veguilla V; Widdowson MA; Fry AM; Brooks WA
    Influenza Other Respir Viruses; 2017 Sep; 11(5):394-398. PubMed ID: 28688210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of QuickVue influenza A+B rapid test for detection of pandemic influenza A/H1N1 2009.
    Velasco JM; Montesa-Develos ML; Jarman RG; Lopez MN; Gibbons RV; Valderama MT; Yoon IK
    J Clin Virol; 2010 Jun; 48(2):120-2. PubMed ID: 20399140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence study of antibodies against influenza A(H1N1) 2009 virus after the second pandemic wave in Slovenia.
    Subelj V; Prosenc K; Sočan M
    Wien Klin Wochenschr; 2012 Mar; 124(5-6):177-80. PubMed ID: 22327938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Importation and spread of pandemic influenza virus A(H1N1) in autonomous province of Vojvodina in preepidemic period].
    Ristić M; Seguljev Z; Nedeljković J; Ilić S; Injac D; Dekić J
    Med Pregl; 2010; 63(7-8):502-5. PubMed ID: 21446138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.